RE: The Mirror23 Jun 2023 06:15
It’s a fair question and one we’d all like to know the answer to, but we are not a one trick pony. I still think Salistick has huge disruptive potential, but the real kicker for us is that we are clearly operating at the forfront of LFT tech, here with Saliva based testing, and with Senzo on PCR accurate LFT.
National Health services in the U.K. and around the world are overburdened, inefficient, and spend huge amounts of money treating conditions which might otherwise have been avoided with a speedier diagnosis. LFT tech can take away some of that burden by empowering people to look after there own health, move health services into telemedicine, and provide speedier diagnosis for conditions like stroke thereby protecting people and saving billions, yes billions.